Home › Post-COVID Conditions (Long COVID) › NCT05741112
The Long COVID-19 Wearable Device Study
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Is at least 18 years old. * Has a self/and or physician diagnosis of: * Long COVID (based on the WHO working definition), * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or * POTS (Postural Orthostatic Tachycardia Syndrome). * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms. * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one. * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly. * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback. * Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies. * Agrees to complete at least 75% of the study surveys. Exclusion Criteria: * As long as they meet inclusion there is no exclusion
About the study
To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.
What is being tested
- Wearable device (device)
Sponsor: Scripps Translational Science Institute · Participants: 100,500 · Started: Nov 16, 2023
Contact the study team
- Andrea Goosen · Phone: 0000000000
Official record on ClinicalTrials.gov — NCT05741112
Locations in the U.S.
| California | Scripps Research, La Jolla |
Conditions
- Post-COVID Conditions (Long COVID)
- Postural Orthostatic Tachycardia Syndrome
- Autonomic Nervous System Disorders
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.